Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4607]

ASCO GI 2022: Pembrolizumab significantly improved OS versus placebo in certain patients with advanced HCC previously treated with sorafenib

ASCO GI 2022: Pembrolizumab significantly improved OS versus placebo in certain patients with advanced HCC...

Combination therapies may improve outcomes due to independent, rather than synergistic or additive, drug action

Combination therapies may improve outcomes due to independent, rather than synergistic or additive, drug action

Immunotherapy before liver cancer surgery can kill tumour, and likely residual cancer cells

Immunotherapy before liver cancer surgery can kill tumour, and likely residual cancer cells

Researchers show increased survival rate in prostate cancer patients with addition of hormone therapy treatments

Researchers show increased survival rate in prostate cancer patients with addition of hormone therapy treatments

Matched targeted treatment based on ESCAT actionable genomic alterations associates with improved prognosis of cholangiocarcinoma patients

Matched targeted treatment based on ESCAT actionable genomic alterations associates with improved prognosis of...

Identification of a novel therapeutic target in multiple myeloma

Identification of a novel therapeutic target in multiple myeloma

New research raises awareness of the dangers of septic shock in blood cancer patients in USA

New research raises awareness of the dangers of septic shock in blood cancer patients in USA

Researchers identifies new drug combo for liver cancer via CRISPR-Cas9 screen

Researchers identifies new drug combo for liver cancer via CRISPR-Cas9 screen

Researchers reduce breast cancer metastasis in animal models by modifying tumour electrical properties

Researchers reduce breast cancer metastasis in animal models by modifying tumour electrical properties

Survival rate of adult patients with relapsed acute lymphoblastic leukaemia after haematopoietic cell transplantation has steadily increased over the past two decades

Survival rate of adult patients with relapsed acute lymphoblastic leukaemia after haematopoietic cell...

More from ecancer